Page last updated: 2024-08-23

simvastatin and Cerebrovascular Disorders

simvastatin has been researched along with Cerebrovascular Disorders in 24 studies

Research

Studies (24)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	12 (50.00)	18.2507
2000's	4 (16.67)	29.6817
2010's	7 (29.17)	24.3611
2020's	1 (4.17)	2.80

Authors

Authors	Studies
Kang, HT; Kim, HS; Kim, J; Lee, JW; Yang, W	1
Hamel, E; Tong, XK; Trigiani, LJ	1
Hamel, E; Tong, XK	1
Amr, G; Azzaoui, R; Bordet, R; Delassus, L; Fossaert, E; Modine, T; Ouk, T; Tailleux, A	1
Teramoto, T	1
Hamel, E; Lecrux, C; Rosa-Neto, P; Tong, XK	1
Arca, M; Budal, S; Degli Esposti, E; Degli Esposti, L; Sangiorgi, D; Vigna, GB	1
Armitage, J; Chen, F; Chen, YP; Chen, ZM; Feng, F; Gao, Y; Hopewell, JC; Hundei, WB; Jiang, LX; Landray, M; Li, J; Li, X; Liu, JM; Valdes-Marquez, E; Zhang, D; Zhang, HB	1
Davalos, A; Fisher, M	1
Armitage, J; Collins, R; Parish, S; Peto, R; Sleight, P	1
Horiuchi, H; Itakura, H; Kita, T; Mabuchi, H; Matsuzaki, M; Matsuzawa, Y; Nakaya, N; Oikawa, S; Saito, Y; Sasaki, J; Shimamoto, K	1
Boop, BS; Hart, RG; Sherman, DG	1
Cooper, ME; Gilbert, RE; Jerums, G	1
Gotto, AM	1
Byington, RP; Crouse, JR; Furberg, CD; Hoen, HM	1
Stiffman, MN	1
Evans, MF; Por, CP; Sabharwal, M	1
Bennett, W	1
Ballantyne, CM; Jacobson, TA; Schein, JR; Williamson, A	1
Echeandia, C; Figuerola, A; Marta-Moreno, J; Mola, S; Oliveros-Cid, A	1
Furberg, CD	1
Coupal, L; Grover, SA; Paquet, S; Zowall, H	1
Yokode, M	1

Reviews

6 review(s) available for simvastatin and Cerebrovascular Disorders

Article	Year
Pitavastatin: clinical effects from the LIVES Study. Atherosclerosis. Supplements, 2011, Volume: 12, Issue:3 Topics: Atorvastatin; Biomarkers; Cardiovascular Diseases; Cerebrovascular Disorders; Cholesterol, HDL; Cholesterol, LDL; Clinical Trials, Phase IV as Topic; Comorbidity; Diabetes Mellitus, Type 2; Dyslipidemias; Glomerular Filtration Rate; Glycated Hemoglobin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Japan; Kidney Diseases; Multicenter Studies as Topic; Muscular Diseases; Prospective Studies; Pyrroles; Quinolines; Risk; Simvastatin; Treatment Outcome; Triglycerides	2011
Emerging therapies for cerebrovascular disorders. Stroke, 2004, Volume: 35, Issue:2 Topics: Angiotensin-Converting Enzyme Inhibitors; Atorvastatin; Cerebrovascular Circulation; Cerebrovascular Disorders; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Intracranial Aneurysm; Pyrroles; Randomized Controlled Trials as Topic; Risk; Simvastatin; Therapeutics; Tissue Plasminogen Activator; Treatment Outcome	2004
Reductase inhibitor monotherapy and stroke prevention. Archives of internal medicine, 1997, Jun-23, Volume: 157, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Anticholesteremic Agents; Cerebrovascular Disorders; Coronary Disease; Female; Humans; Hydroxymethylglutaryl CoA Reductases; Incidence; Lovastatin; Male; Middle Aged; Pravastatin; Simvastatin; Treatment Outcome	1997
Maximizing the cost-effectiveness of lipid-lowering therapy. Archives of internal medicine, 1998, Oct-12, Volume: 158, Issue:18 Topics: Anticholesteremic Agents; Atorvastatin; Carotid Stenosis; Cerebrovascular Disorders; Clinical Trials as Topic; Coronary Disease; Cost-Benefit Analysis; Fatty Acids, Monounsaturated; Fluvastatin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Lovastatin; Pravastatin; Pyrroles; Simvastatin	1998
[Statins (HMG-CoA reductase inhibitors), cholesterol and stroke]. Revista de neurologia, 1998, Volume: 27, Issue:159 Topics: Adult; Arteriosclerosis; Cerebrovascular Disorders; Cholesterol; Clinical Trials as Topic; Drug Evaluation; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Ischemic Attack, Transient; Lipoproteins, HDL; Lipoproteins, LDL; Lovastatin; Male; Middle Aged; Pravastatin; Risk Factors; Simvastatin; Triglycerides	1998
[Advance in clinical studies on atherosclerosis]. Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics, 2000, Volume: 37, Issue:3 Topics: Animals; Anticholesteremic Agents; Arteriosclerosis; Cerebrovascular Disorders; Coronary Disease; Humans; Randomized Controlled Trials as Topic; Simvastatin	2000

Trials

1 trial(s) available for simvastatin and Cerebrovascular Disorders

Article	Year
Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions. Lancet (London, England), 2004, Mar-06, Volume: 363, Issue:9411 Topics: Adult; Aged; Anticholesteremic Agents; Arterial Occlusive Diseases; Brain Ischemia; Cerebrovascular Disorders; Cholesterol, LDL; Clinical Trials as Topic; Coronary Disease; Female; Humans; Incidence; Male; Middle Aged; Peripheral Nervous System Diseases; Placebos; Simvastatin; Stroke; Treatment Outcome	2004

Article

Year

Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions.

Lancet (London, England), 2004, Mar-06, Volume: 363, Issue:9411

Topics: Adult; Aged; Anticholesteremic Agents; Arterial Occlusive Diseases; Brain Ischemia; Cerebrovascular Disorders; Cholesterol, LDL; Clinical Trials as Topic; Coronary Disease; Female; Humans; Incidence; Male; Middle Aged; Peripheral Nervous System Diseases; Placebos; Simvastatin; Stroke; Treatment Outcome

2004

Other Studies

17 other study(ies) available for simvastatin and Cerebrovascular Disorders

Article	Year
Primary Prevention of Cardiocerebrovascular Diseases and Related Deaths According to Statin Type. International journal of environmental research and public health, 2020, 08-30, Volume: 17, Issue:17 Topics: Adult; Aged; Atorvastatin; Cardiovascular Diseases; Cerebrovascular Disorders; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Middle Aged; Pravastatin; Primary Prevention; Pyrroles; Quinolines; Retrospective Studies; Rosuvastatin Calcium; Simvastatin	2020
High cholesterol triggers white matter alterations and cognitive deficits in a mouse model of cerebrovascular disease: benefits of simvastatin. Cell death & disease, 2019, 01-28, Volume: 10, Issue:2 Topics: Animals; Cerebrovascular Disorders; Cognition Disorders; Disease Models, Animal; Hypercholesterolemia; Male; Mice; Mice, Transgenic; Simvastatin; White Matter	2019
Simvastatin restored vascular reactivity, endothelial function and reduced string vessel pathology in a mouse model of cerebrovascular disease. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2015, Volume: 35, Issue:3 Topics: Animals; Blotting, Western; Brain; Cerebral Arteries; Cerebrovascular Disorders; Disease Models, Animal; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunohistochemistry; Maze Learning; Mice; Mice, Inbred C57BL; Mice, Transgenic; Muscle Contraction; Muscle, Smooth, Vascular; Neuroprotective Agents; Rats; Simvastatin	2015
Lipid-lowering drugs prevent neurovascular and cognitive consequences of cardiopulmonary bypass. Vascular pharmacology, 2016, Volume: 80 Topics: Animals; Avoidance Learning; Cardiopulmonary Bypass; Cerebrovascular Disorders; Cognition Disorders; Endothelium, Vascular; Fenofibrate; Hemodynamics; Hypolipidemic Agents; Lipids; Male; Maze Learning; Neurons; Neuroprotective Agents; Rats, Sprague-Dawley; Simvastatin; Tumor Necrosis Factor-alpha; Vasodilation	2016
Age-dependent rescue by simvastatin of Alzheimer's disease cerebrovascular and memory deficits. The Journal of neuroscience : the official journal of the Society for Neuroscience, 2012, Apr-04, Volume: 32, Issue:14 Topics: Aging; Alzheimer Disease; Animals; Cerebrovascular Circulation; Cerebrovascular Disorders; Female; Humans; Male; Memory Disorders; Mice; Mice, Inbred C57BL; Mice, Transgenic; Simvastatin	2012
[Achievement of therapeutic target in subjects on statin treatment in clinical practice. Results of the STAR (Statins Target Assessment in Real practice) study]. Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace, 2011, Volume: 76, Issue:4 Topics: Aged; Algorithms; Azetidines; Biomarkers; Cardiovascular Diseases; Cerebrovascular Disorders; Cholesterol, LDL; Cohort Studies; Diabetes Complications; Diabetes Mellitus; Ezetimibe; Female; Fluorobenzenes; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Italy; Lovastatin; Male; Medication Adherence; Middle Aged; Pravastatin; Pyrimidines; Retrospective Studies; Risk Assessment; Risk Factors; Rosuvastatin Calcium; Simvastatin; Sulfonamides; Treatment Outcome	2011
Use of secondary preventive medications in patients with atherosclerotic disease in urban China: a cross-sectional study of 16, 860 patients. Chinese medical journal, 2012, Volume: 125, Issue:24 Topics: Aged; Aged, 80 and over; Atherosclerosis; Atorvastatin; Cerebrovascular Disorders; Coronary Artery Disease; Cross-Sectional Studies; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Peripheral Vascular Diseases; Pyrroles; Secondary Prevention; Simvastatin	2012
Primary cardiovascular events and serum lipid levels in elderly Japanese with hypercholesterolemia undergoing 6-year simvastatin treatment: a subanalysis of the Japan lipid intervention trial. Journal of the American Geriatrics Society, 2004, Volume: 52, Issue:12 Topics: Adult; Age Distribution; Aged; Anticholesteremic Agents; Asian; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Disease; Female; Hawaii; Humans; Hypercholesterolemia; Incidence; Japan; Lipids; Male; Middle Aged; Proportional Hazards Models; Risk; Simvastatin; Survival Analysis	2004
Cholesterol lowering and the risk of stroke. Archives of internal medicine, 1996, Jan-22, Volume: 156, Issue:2 Topics: Anticholesteremic Agents; Cerebrovascular Disorders; Clinical Trials as Topic; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Risk; Simvastatin	1996
Primary prevention of stroke. The New England journal of medicine, 1996, Apr-25, Volume: 334, Issue:17 Topics: Acyl Coenzyme A; Anticholesteremic Agents; Arteriosclerosis; Cerebrovascular Disorders; Controlled Clinical Trials as Topic; Enzyme Inhibitors; Humans; Hypercholesterolemia; Lovastatin; Meta-Analysis as Topic; Oxidoreductases; Pravastatin; Simvastatin	1996
Stain therapy and reduced incidence of stroke. Implications of cholesterol-lowering therapy for cerebrovascular disease. Archives of internal medicine, 1997, Jun-23, Volume: 157, Issue:12 Topics: Anticholesteremic Agents; Cerebrovascular Disorders; Clinical Trials as Topic; Coronary Disease; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Lovastatin; Simvastatin	1997
HMG-CoA reductase inhibitors reduce stroke risk, total mortality. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1997, Oct-01, Volume: 54, Issue:19 Topics: Cerebrovascular Disorders; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lovastatin; Meta-Analysis as Topic; Mortality; Pravastatin; Simvastatin	1997
"Statin" drugs, mortality, and stroke prevention. The Journal of family practice, 1997, Volume: 45, Issue:4 Topics: Cerebrovascular Disorders; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Meta-Analysis as Topic; Mortality; Pravastatin; Randomized Controlled Trials as Topic; Reproducibility of Results; Simvastatin	1997
Do statin drugs lower the risk of stroke? Canadian family physician Medecin de famille canadien, 1998, Volume: 44 Topics: Anticholesteremic Agents; Cerebrovascular Disorders; Coronary Disease; Humans; Lovastatin; Meta-Analysis as Topic; Pravastatin; Risk Factors; Simvastatin	1998
Statins. The New Zealand medical journal, 1998, May-22, Volume: 111, Issue:1066 Topics: Anticholesteremic Agents; Cerebrovascular Disorders; Cholesterol; Fatty Acids, Monounsaturated; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Male; Simvastatin	1998
Natural statins and stroke risk. Circulation, 1999, Jan-19, Volume: 99, Issue:2 Topics: Anticholesteremic Agents; Cerebrovascular Disorders; Humans; Myocardial Infarction; Pravastatin; Simvastatin	1999
Cost-effectiveness of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors in the secondary prevention of cardiovascular disease: forecasting the incremental benefits of preventing coronary and cerebrovascular events. Archives of internal medicine, 1999, Mar-22, Volume: 159, Issue:6 Topics: Adult; Aged; Canada; Cardiovascular Diseases; Cerebrovascular Disorders; Cost-Benefit Analysis; Drug Costs; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Life Expectancy; Male; Middle Aged; Recurrence; Risk; Scandinavian and Nordic Countries; Sensitivity and Specificity; Simvastatin	1999